{
    "2019-02-11": [
        [
            {
                "time": "2019-02-11",
                "original_text": "FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma",
                "features": {
                    "keywords": [
                        "FDA",
                        "sBLA",
                        "Priority Review",
                        "BAVENCIO",
                        "INLYTA",
                        "Advanced Renal Cell Carcinoma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "After Hours Most Active for Feb 11, 2019: SNAP, BAC, ELAN, FDC, PFE, MGM, FOMX, EMB, FB, EBAY, JBLU, CELG",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Most Active",
                        "SNAP",
                        "BAC",
                        "PFE"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer",
                "features": {
                    "keywords": [
                        "Phase 3",
                        "ARCHES Trial",
                        "XTANDI",
                        "Radiographic Progression-Free Survival",
                        "Prostate Cancer"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Stocks Start Week of Trade Talks on Muted Note: Markets Wrap",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Trade Talks",
                        "Muted Note"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "economy",
                        "trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Stocks making the biggest moves midday: Avis Budget Group, Pfizer, Tesla & more",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Biggest Moves",
                        "Avis Budget Group",
                        "Pfizer",
                        "Tesla"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "automotive",
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Exchange Offer",
                        "Elanco Stake"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "See Which Of The Latest 13F Filers Holds Pfizer",
                "features": {
                    "keywords": [
                        "13F Filers",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod",
                "features": {
                    "keywords": [
                        "Dow 30",
                        "Disney Earnings",
                        "Pfizer",
                        "Cancer Drug",
                        "CHMP Nod"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "entertainment",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-11",
                "original_text": "Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Q4 Earnings",
                        "MRK",
                        "LLY",
                        "CHMP Nod"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}